Canada - English - Health Canada

genentech inc - somatrem; water - powder for solution - 5mg; 10ml - somatrem 5mg; water 10ml - pituitary

Canada - English - Health Canada

genentech inc - somatrem; water - liquid - 10mg; 20ml - somatrem 10mg; water 20ml - pituitary

Canada - English - Health Canada

hoffmann-la roche limited - somatrem; water - liquid - 10mg; 10ml - somatrem 10mg; water 10ml - pituitary

Canada - English - Health Canada

hoffmann-la roche limited - somatrem; water - liquid - 5mg; 10ml - somatrem 5mg; water 10ml - pituitary

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - dibasic sodium phosphate 0.7mg; glycine 37mg; somatrem 4 [iu] - solution for injection - 37mg/4iu/0.7mg - active: dibasic sodium phosphate 0.7mg glycine 37mg somatrem 4 [iu]

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

bm_squib -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - fludrocortisone acetate -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - triamcinolone acetonide -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - triamcinolone acetonide -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - triamcinolone acetonide, quantity: 10 mg/ml - injection, suspension - excipient ingredients: carmellose sodium; polysorbate 80; benzyl alcohol; sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - intra-articular: kenacort-a 10 injection (sterile triamcinolone acetonide suspension usp) is indicated for intra-articular or intrasynovial administration, and for injections into tendon sheaths, as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: synovitis of osteoarthritis, rheumatoid arthritis, acute and subacute bursitis, acute gouty arthritis, epicondylitis, acute non-specific tenosynovitis, post-traumatic osteoarthritis. intradermal: intralesional administration of kenacort-a 10 injection is indicated for the treatment of keloids, discoid lupus erythermatous, necrobiosis lipoidica diabeticorum, alopecia areata and localised hypertrophic, infiltrated, inflammatory lesions of: lichen planus, psoriatic plaques, granuloma annulare, and lichen simplex chronicus ( neurodermatitis), kenacort-a 10 injection also may be useful in cystic tumours of an aponeurosis or tendon ( ganglia).